Why is Shukra Pharma. falling/rising?

As of 07-Oct, Shukra Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 33.10, which represents a decrease of 0.67 or 1.98%. The stock has been underperforming, having fallen for the last four consecutive days, resulting in a total return of -7.7% over the past week. Additionally, the stock's performance today has underperformed its sector by 2.29%. Despite its strong long-term performance, with a year-to-date increase of 142.72% and a staggering 369.70% rise over the past year, the recent trend indicates a significant drop in investor participation, with delivery volume decreasing by 31.77% compared to the five-day average.
In the broader market context, the Sensex has shown a positive return of 2.07% over the past week, contrasting sharply with Shukra Pharmaceuticals' decline. This suggests that while the overall market is experiencing gains, Shukra Pharmaceuticals is struggling to maintain its momentum. The stock remains above its longer-term moving averages but is currently below its five-day moving average, indicating a short-term weakness. The absence of specific positive or negative factors further complicates the analysis of the stock's recent performance, leaving a gap in understanding the underlying reasons for the decline.